Certara Inc

CERT

Company Profile

  • Business description

    Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

  • Contact

    4 Radnor Corporate Center
    Suite 350
    RadnorPA19087
    USA

    T: +1 415 237-8272

    https://www.certara.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Health Information Services

    Fiscal Year End

    31 December 2026

    Employees

    1,576

Stocks News & Analysis

stocks

Nvidia dominance continues

Our view on the latest earnings report.
stocks

Chart of the Week: Recent selloffs in this ASX sector opens doors to opportunity

Ongoing rate hikes have investors spooked.
stocks

ASX dividend champions: Stocks, ETFs and LICs

Mark and Shani run through lessons for ASX stocks, ETFs and LICs that have delivered over the past decade.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,840.809.50-0.11%
CAC 408,086.0031.42-0.39%
DAX 4024,606.77130.47-0.53%
Dow JONES (US)50,285.66276.310.55%
FTSE 10010,443.4711.130.11%
HKSE25,386.52264.60-1.03%
NASDAQ26,293.1022.740.09%
Nikkei 22561,684.141,879.733.14%
NZX 50 Index12,878.07117.040.92%
S&P 5007,445.7212.750.17%
S&P/ASX 2008,621.706.30-0.07%
SSE Composite Index4,077.2884.91-2.04%

Market Movers